Insight Pharma Newsletter November 2022

Dear Reader :

This month’s edition of Pharma Intelligence’s newsletter, developed in alliance with the IPA, spotlights distinct shifts and action in the clinical trials arena.

We take a deep dive into how the Asia-Pacific region has emerged as a trial hotspot over the past decade; notably, India led the way for COVID-19 treatment trials, though China was tops with most vaccine trial starts. The trials segment also continues to attract big US retailers – we have a piece on latest entrant Walmart.

There’s also a fascinating write-up on how artificial intelligence is beginning to transform biologics drug discovery. 2021 saw 30 deals between pharma companies and AI-native biologics firms.

Anju Ghangurde - Executive Editor (Asia Pacific), Scrip/Pink Sheet
Dr. Shridhar Narayanan - Senior Technical Advisor - Innovation, IPA

Register-for-IPA-Enhancing-Pharma-RD-Webinar

Perspective from Industry Leaders


US FDA’s New Acting Generics Chief Relearning System After 24 Years Of Experience	Pfizer R&D Chief Mikael Dolsten Reflects On The COVID-19 Pandemic Experience
In the first part of an exclusive two-part interview, Samsung Bioepis’ development division leader Kyung-Ah Kim...	I still remember how I screamed 'oh my god, it's just unbelievable,'" worldwide president R&D Mikael Dolsten told Scrip.

LICENSING & COLLABORATION AGREEMENTS


MPP Strikes Landmark Licensing Deal With Novartis On Nilotinib	Deal Watch: OrsoBio Reveals Its Metabolic Health Focus With Four Licensing Pacts
The Medicines Patent Pool has struck a milestone voluntary licensing deal with new partner Novartis for nilotinib to treat chronic myeloid leukemia.	California biotech also notes prior licensing deal with Gilead for mitochondrial candidate. Twentyeight-Seven acquires RNA-splicing cancer candidate from Basilea.

NEXT GEN: R&D


AI In Biologics Discovery: An Emerging Frontier	Sparta Breaks Through With Synthetic Cartilage To Address Osteoarthritis
AI is beginning to transform biologics discovery. The power of algorithms used in biologics discovery has increased over the last decade, and today between 50 and 60 AI-enabled biologics are in different stages...	Sparta Biomedical is developing a synthetic cartilage-on-titanium knee implant based on its proprietary Galene process for infusing cellulose fibers with polyvinyl alcohol.

CLINICAL TRIALS


APAC As A Clinical Trial Powerhouse	Trials In Focus: Walmart Joins Growing List Of Retailers Entering Clinical Research
In the last 10 years, APAC has become a hotspot for clinical trials: the region contributed almost 50% of new clinical trial activity globally in 2021.	SIGA provides an update on its monkeypox program, while Massive Bio announces progress on its AI platform for connecting cancer patients to trials...

Citeline Contact

Poornachandra Tejasvi .K, Senior Director - Emerging Markets, India

Direct: +91 11143155159
Mobile: +91 9945273146
Email: poornachandra.tejasvi@informa.com

Client Services: clientservices@pharmaintel.informa.com

IPA Contact

Direct: +91 022 2610 9281
Email: info@ipa-india.org